期刊文献+

《病理性近视眼眼底改变》一书出版

原文传递
导出
摘要 由方严、石一宁主编的《病理性近视眼眼底改变》一书受国家科学技术学术著作出版基金资助、已由科学技术文献出版社出版。本书全面介绍了近年来国内外对病理性近视眼眼底改变的研究进展。作者结合自己工作中的临床研究资料并系统复习病理性近视眼相关文献,分别从病理性近视眼概论、病理性近视眼眼底改变的分类及演变、豹纹状眼底、后葡萄肿、
作者 方严
出处 《国际眼科纵览》 2013年第5期291-291,共1页 International Review of Ophthalmology
  • 相关文献

参考文献80

  • 1Srinivasan VJ, Monson BK,Wojtkowski M,et al. Characteriza-tion of outer retinal morphology with high-speed,ultrahigh-resolu-tion optical coherence tomography. Invest Ophthalmol Vis Sci,2008,49: 1571-1579.
  • 2Rii T, Itoh Y, Inoue M,et al. Foveal cone outer segment tips lineand disruption artifacts in spectral-domain optical coherence tomo-graphic images of normal eyes. Am J Ophthalmol, 2012,153 :524-529.
  • 3Spaide RF, Curcio CA. Anatomical correlates to the bands seen inthe outer retina by optical coherence tomography: literature reviewand model. Retina, 2011, 31 : 1609-1619.
  • 4Krishnan R, Tossounis C, Fung Yang Y. 20-gauge and 23-gaugephacovitrectomy for idiopathic macular holes : comparison of com-plications and long-term outcomes. Eye ( Lond),2013,27: 72-77.
  • 5Wakabayashi T, Fujiwara M, Sakaguchi H, et al. Foveal micro-structure and visual acuity in surgically closed macular holes :spectral-domain optical coherence tomographic analysis. Ophthal-mology, 2010,117: 1815-1824.
  • 6Ooka E, Mitamura Y, Baba T, et al. Foveal microstructure onspectral-domain optical coherence tomographic images and visualfunction after macular hole surgery. Am J Ophthalmol, 2011,152: 283-290.
  • 7Theodossiadis PG, Grigoropoulos VG, Theodossiadis GP. The sig-nificance of the external limiting membrane in the recovery of pho-toreceptor layer after successful macular hole closure : a study byspectral domain optical coherence tomography. Ophthalmologica,2011,225: 176-184.
  • 8Landa G, Gentile RC, Garcia PMT, et al. External limiting mem-brane and visual outcome in macular hole repair : spectral domainOCT analysis. Eye, 2012, 26: 61-69.
  • 9Itoh Y, Inoue M, Rii T, et al. Significant correlation between vis-ual acuity and recovery of foveal cone microstructures after macularhole surgery. Am J Ophthalmol, 2012,153: 111-119.
  • 10Chen WC , Wang Y, Li XX. Morphologic and functional evalua-tion before and after successful macular hole surgery using spec-tral-domain optical coherence tomography combined with micrope-rimetry. Retina,2012, 32: 1733-1742.

二级参考文献27

  • 1Rosenfeld PJ, Brown DM, Heier JS, et al. Ranihizumah forneovascular age-related macular degeneration. N Engl J Med,2006,355:1419-1431.
  • 2Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versusverteporfin photodynamic therapy for neovascular age-relatedmacular degeneration : two-year results of the ANCHOR study.Ophthalmology, 2009, 116:57-65.
  • 3Heier JS, Boyer D, Nguyen QD, et al. The 1 -year results ofCLEAR-IT 2,a phase 2 study of vascular endothelial growth factortrap-eye dosed as-needed after 12-week fixed dosing.Ophthalmology, 2011,118:1098-1106.
  • 4Gragoudas ES, Adamis AP,Cunningham ET, et al. Pegaptanibfor neovascular age-related macular degeneration. N Engl J Med,2004,351:1805-1816.
  • 5Li XX, Hu YH, Sun XD, et al. Bevacizumab for neovascular age-related macular degeneration in China. Ophthalmology, 2012 , Inpress.
  • 6Martin DF, Maguire MG, Ying GS, et al. Ranibizumab andBevacizumab for neovascular age-related macular degeneration. NEngl J Med, 2011,364 : 1897-1908.
  • 7Zhang M,Zhang J, Yan M, et al. A phase 1 study of KH902 , avascular endothelial growth factor receptor decoy, for exudativeage-related macular degeneration. Ophthalmology, 2011,118:672-678.
  • 8Kaiser PK, Symons RC,Shah SM, et al. Sirna-027 StudyInvestigators RNAi-based treatment for neovascular age-relatedmacular degeneration by Sirna-027. Am J Ophthalmol, 2010,150:33-39.
  • 9Larsen M, Schmidt-Erfurth U, Lanzetta P, et al. Verteporfin plusRanibizumab for choroidal neovascularization in age-relatedmacular degeneration : twelve-month MONT BLANC study results.Ophthalmology, 2012 , 119:992-1000.
  • 10Koh A, Lee WK, Chen LJ, et al. Everest study : efficacy andsafety of verteporfin photodynamic therapy in combination withRanibizumab or alone versus Ranibizumab monotherapy in patientswith symptomatic macular polypoidal choroidal vasculopathy.Retina, 2012,In press.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部